Related references
Note: Only part of the references are listed.Pioglitazone and bladder cancer: a propensity score matched cohort study
Li Wei et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2013)
Does Insulin Glargine Increase the Risk of Cancer Compared With Other Basal Insulins? A French nationwide cohort study based on national administrative databases
Jean-Paul Fagot et al.
DIABETES CARE (2013)
Risk of Hepatocellular Carcinoma in Diabetic Patients and Risk Reduction Associated With Anti-Diabetic Therapy: A Population-Based Cohort Study
Shih-Wei Lai et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2012)
Use of thiazolidinediones and the risk of bladder cancer among people with type 2 diabetes: a meta-analysis
Isabelle N. Colmers et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2012)
Pioglitazone and Bladder Cancer A population-based study of Taiwanese
Chin-Hsiao Tseng
DIABETES CARE (2012)
Increased risk of bladder cancer with pioglitazone therapy in patients with diabetes: A meta-analysis
Zhaowei Zhu et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2012)
Glucose-lowering agents and the patterns of risk for cancer: a study with the General Practice Research Database and secondary care data
T. P. van Staa et al.
DIABETOLOGIA (2012)
Pioglitazone and risk of bladder cancer among diabetic patients in France: a population-based cohort study
A. Neumann et al.
DIABETOLOGIA (2012)
The Influence of Type 2 Diabetes and Glucose-Lowering Therapies on Cancer Risk in the Taiwanese
Ming-Chia Hsieh et al.
EXPERIMENTAL DIABETES RESEARCH (2012)
Association of thiazolidinediones with liver cancer and colorectal cancer in type 2 diabetes mellitus
Chia-Hsuin Chang et al.
HEPATOLOGY (2012)
Oral Insulin Secretagogues, Insulin, and Cancer Risk in Type 2 Diabetes Mellitus
Chia-Hsuin Chang et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Association Between Longer Therapy With Thiazolidinediones and Risk of Bladder Cancer: A Cohort Study
Ronac Mamtani et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2012)
Basal Insulin and Cardiovascular and Other Outcomes in Dysglycemia
Hertzel C. Gerstein et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Cancer Risk in Diabetic Patients Treated with Metformin: A Systematic Review and Meta-analysis
Hiroshi Noto et al.
PLOS ONE (2012)
Significantly increased risk of cancer in diabetes mellitus patients: A meta-analysis of epidemiological evidence in Asians and non-Asians
Hiroshi Noto et al.
JOURNAL OF DIABETES INVESTIGATION (2012)
The use of pioglitazone and the risk of bladder cancer in people with type 2 diabetes: nested case-control study
Laurent Azoulay et al.
BMJ-BRITISH MEDICAL JOURNAL (2012)
Prostate cancer mortality in Taiwanese men: Increasing age-standardized trend in general population and increased risk in diabetic men
Chin-Hsiao Tseng
ANNALS OF MEDICINE (2011)
Type 2 diabetes increases and metformin reduces total, colorectal, liver and pancreatic cancer incidences in Taiwanese: a representative population prospective cohort study of 800,000 individuals
Meei-Shyuan Lee et al.
BMC CANCER (2011)
Safety of dipeptidyl peptidase-4 inhibitors: a meta-analysis of randomized clinical trials
Matteo Monami et al.
CURRENT MEDICAL RESEARCH AND OPINION (2011)
Diabetes and Risk of Prostate Cancer A study using the National Health Insurance
Chin-Hsiao Tseng
DIABETES CARE (2011)
Further Exploration of the Relationship Between Insulin Glargine and Incident Cancer A retrospective cohort study of older Medicare patients
Nancy E. Morden et al.
DIABETES CARE (2011)
Risk of Bladder Cancer Among Diabetic Patients Treated With Pioglitazone Interim report of a longitudinal cohort study
James D. Lewis et al.
DIABETES CARE (2011)
Assessing the Association of Pioglitazone Use and Bladder Cancer Through Drug Adverse Event Reporting
Carlo Piccinni et al.
DIABETES CARE (2011)
Intensive glucose control and risk of cancer in patients with type 2 diabetes
G. Stefansdottir et al.
DIABETOLOGIA (2011)
Diabetes and risk of bladder cancer: a study using the National Health Insurance database in Taiwan
C-H. Tseng
DIABETOLOGIA (2011)
SIGNIFICANTLY INCREASED RISK OF CANCER IN PATIENTS WITH DIABETES MELLITUS: A SYSTEMATIC REVIEW AND META-ANALYSIS
Hiroshi Noto et al.
ENDOCRINE PRACTICE (2011)
Minireview: IGF, Insulin, and Cancer
Emily J. Gallagher et al.
ENDOCRINOLOGY (2011)
Pancreatitis, Pancreatic, and Thyroid Cancer With Glucagon-Like Peptide-1-Based Therapies
Michael Elashoff et al.
GASTROENTEROLOGY (2011)
Pioglitazone and bladder cancer
Dominique Hillaire-Buys et al.
LANCET (2011)
Diabetes Mellitus, Fasting Glucose, and Risk of Cause-Specific Death
Sreenivasa Rao Kondapally Seshasai et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Metformin and Cancer Risk in Diabetic Patients: A Systematic Review and Meta-analysis
Andrea DeCensi et al.
CANCER PREVENTION RESEARCH (2010)
Metformin Prevents Tobacco Carcinogen-Induced Lung Tumorigenesis
Regan M. Memmott et al.
CANCER PREVENTION RESEARCH (2010)
Diabetes, Insulin Use, and Cancer Risk: Are Observational Studies Part of the Solution-or Part of the Problem?
Jeffrey A. Johnson et al.
DIABETES (2010)
Associations of Hyperglycemia and Insulin Usage With the Risk of Cancer in Type 2 Diabetes: The Hong Kong Diabetes Registry
Xilin Yang et al.
DIABETES (2010)
Postoperative Mortality in Cancer Patients With Preexisting Diabetes Systematic review and meta-analysis
Bethany B. Barone et al.
DIABETES CARE (2010)
Diabetes and Cancer A consensus report
Edward Giovannucci et al.
DIABETES CARE (2010)
Use of sulphonylurea and cancer in type 2 diabetes-The Hong Kong Diabetes Registry
Xilin Yang et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2010)
Diabetes therapy and cancer risk: causal effects and other plausible explanations
S. Hernandez-Diaz et al.
DIABETOLOGIA (2010)
Metformin blocks the stimulative effect of a high-energy diet on colon carcinoma growth in vivo and is associated with reduced expression of fatty acid synthase
Carolyn Algire et al.
ENDOCRINE-RELATED CANCER (2010)
Metformin: Taking away the candy for cancer?
Mathilde Jalving et al.
EUROPEAN JOURNAL OF CANCER (2010)
Substantially increased risk of cancer in patients with diabetes mellitus A systematic review and meta-analysis of epidemiologic evidence in Japan
Hiroshi Noto et al.
JOURNAL OF DIABETES AND ITS COMPLICATIONS (2010)
Metformin Suppresses Azoxymethane-Induced Colorectal Aberrant Crypt Foci by Activating AMP-Activated Protein Kinase
Kunihiro Hosono et al.
MOLECULAR CARCINOGENESIS (2010)
Diabetes Mellitus and Increased Risk of Cancer: Focus on Metformin and the Insulin Analogs
M. Shawn McFarland et al.
PHARMACOTHERAPY (2010)
Effects of Pioglitazone, a Peroxisome Proliferator-Activated Receptor Gamma Agonist, on the Urine and Urothelium of the Rat
Shugo Suzuki et al.
TOXICOLOGICAL SCIENCES (2010)
Causes of death in Japanese diabetics: A questionnaire survey of 18,385 diabetics over a 10-year period
Nigishi Hotta et al.
JOURNAL OF DIABETES INVESTIGATION (2010)
Sulphonylureas and cancer: a case-control study
Matteo Monami et al.
ACTA DIABETOLOGICA (2009)
Combined randomised controlled trial experience of malignancies in studies using insulin glargine
P. D. Home et al.
DIABETOLOGIA (2009)
Similar risk of malignancy with insulin glargine and neutral protamine Hagedorn (NPH) insulin in patients with type 2 diabetes: findings from a 5 year randomised, open-label study
J. Rosenstock et al.
DIABETOLOGIA (2009)
Does diabetes therapy influence the risk of cancer?
U. Smith et al.
DIABETOLOGIA (2009)
Insulin glargine use and short-term incidence of malignancies-a population-based follow-up study in Sweden
J. M. Jonasson et al.
DIABETOLOGIA (2009)
Use of insulin glargine and cancer incidence in Scotland: a study from the Scottish Diabetes Research Network Epidemiology Group
H. M. Colhoun
DIABETOLOGIA (2009)
The influence of glucose-lowering therapies on cancer risk in type 2 diabetes
C. J. Currie et al.
DIABETOLOGIA (2009)
Risk of malignancies in patients with diabetes treated with human insulin or insulin analogues: a cohort study
L. G. Hemkens et al.
DIABETOLOGIA (2009)
Antidiabetic Therapies Affect Risk of Pancreatic Cancer
Donghui Li et al.
GASTROENTEROLOGY (2009)
Diabetes in Asia Epidemiology, Risk Factors, and Pathophysiology
Juliana C. N. Chan et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Metformin and Pathologic Complete Responses to Neoadjuvant Chemotherapy in Diabetic Patients With Breast Cancer
Sao Jiralerspong et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Epidemiology of pancreatic cancer: an overview
Sara Raimondi et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2009)
Blood Glucose and Risk of Incident and Fatal Cancer in the Metabolic Syndrome and Cancer Project (Me-Can): Analysis of Six Prospective Cohorts
Tanja Stocks et al.
PLOS MEDICINE (2009)
Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy A consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes
David M. Nathan et al.
DIABETES CARE (2009)
Development and validation of a total coronary heart disease risk score in type 2 diabetes mellitus
Xilin Yang et al.
AMERICAN JOURNAL OF CARDIOLOGY (2008)
Type 2 diabetes mellitus and risk of non-Hodgkin lymphoma: A systematic review and meta-analysis
Chun Chao et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2008)
Daily total physical activity level and total cancer risk in men and women: Results from a large-scale population-based cohort study in Japan
Manami Inoue et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2008)
The Effects of Adiponectin and Metformin on Prostate and Colon Neoplasia Involve Activation of AMP-Activated Protein Kinase
Mahvash Zakikhani et al.
CANCER PREVENTION RESEARCH (2008)
AGE-RAGE system and carcinogenesis
Riichiro Abe et al.
CURRENT PHARMACEUTICAL DESIGN (2008)
Rosiglitazone no longer recommended
[Anonymous]
LANCET (2008)
Diabetes mellitus, body size and bladder cancer risk in a prospective study of Swedish men
Susanna C. Larsson et al.
EUROPEAN JOURNAL OF CANCER (2008)
Long-term All-Cause Mortality in Cancer Patients With Preexisting Diabetes Mellitus A Systematic Review and Meta-analysis
Bethany B. Barone et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)
Low testosterone levels are common and associated with insulin resistance in men with diabetes
Mathis Grossmann et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies
Andrew G. Renehan et al.
LANCET (2008)
Long-term mortality after gastric bypass surgery
Ted D. Adams et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Diabetes mellitus and risk of breast cancer: A meta-analysis
Susanna C. Larsson et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Diabetes mellitus and risk of endometrial cancer: a meta-analysis
E. Friberg et al.
DIABETOLOGIA (2007)
Association between cancer prevalence and use of thiazolidinediones: results from the Vermont Diabetes Information System
Maria E. Ramos-Nino et al.
BMC MEDICINE (2007)
A meta-analysis of diabetes mellitus and the risk of prostate cancer
Jocelyn S. Kasper et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2006)
Diabetes mellitus and the risk of cancer - Results from a large-scale population-based cohort study in Japan
Manami Inoue et al.
ARCHIVES OF INTERNAL MEDICINE (2006)
Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data
Alan D. Lopez et al.
LANCET (2006)
Hepatitis C infection and diabetes
H Noto et al.
JOURNAL OF DIABETES AND ITS COMPLICATIONS (2006)
The association between diabetes and hepatocellular carcinoma: A systematic review of epidemiologic evidence
HB El-Serag et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2006)
Enhanced mitogenic signaling in skeletal muscle of women with polycystic ovary syndrome
A Corbould et al.
DIABETES (2006)
Innate immunity gone awry: Linking microbial infections to chronic inflammation and cancer
M Karin et al.
CELL (2006)
Diabetes mellitus and risk of colorectal cancer: A meta-analysis
SC Larsson et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2005)
Type-II diabetes and pancreatic cancer:: a meta-analysis of 36 studies
R Huxley et al.
BRITISH JOURNAL OF CANCER (2005)
Fasting serum glucose level and cancer risk in Korean men and women
SH Jee et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
Therapy Insight: influence of type 2 diabetes on the development, treatment and outcomes of cancer
LC Richardson et al.
NATURE CLINICAL PRACTICE ONCOLOGY (2005)
Mortality and causes of death in a national sample of diabetic patients in Taiwan
CH Tseng
DIABETES CARE (2004)
Diabetes mellitus and risk of prostate cancer: a meta-analysis
S Bonovas et al.
DIABETOLOGIA (2004)
Insulin therapy and colorectal cancer risk among type 2 diabetes mellitus patients
YX Yang et al.
GASTROENTEROLOGY (2004)
Cancer incidence in patients with type 1 diabetes mellitus:: A population-based cohort study in Sweden
K Zendehdel et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2003)
Prevention of pancreatic cancer induction in hamsters by metformin
MB Schneider et al.
GASTROENTEROLOGY (2001)
Abnormal glucose metabolism and pancreatic cancer mortality
SM Gapstur et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2000)
Share Paper
